FBXO32 and metastatic malignant neoplasm: Extending these findings to cancer metastasis as an example of disease EMT, we found that FBXO32 was strongly amplified in metastatic cancers, and its depletion in a NSG mouse xenograft model significantly inhibited tumor growth and metastasis.